Mary Sue Wester, MD in New Hope, MN - Preventive Medicine

Mary Sue Wester, MD is a Preventive Medicine - Occupational Medicine physician based in New Hope, Minnesota. Mary Sue Wester is licensed to practice in Minnesota (license number 17655) and her current practice location is 6101 Virginia Ave. N, New Hope, Minnesota. She can be reached at her office (for appointments etc.) via phone at (763) 537-6307.

NPI number for Mary Sue Wester is 1538706726 and her current mailing address is 6101 Virginia Ave. N, New Hope, Minnesota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1538706726.

Contact Information

	Mary Sue Wester, MD
	6101 Virginia Ave. N, New Hope, MN 55428
	(763) 537-6307
	Not Available

Physician's Profile

Full Name	Mary Sue Wester
Gender	Female
Speciality	Preventive Medicine - Occupational Medicine
Location	6101 Virginia Ave. N, New Hope, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1538706726
Provider Enumeration Date: 12/06/2019
Last Update Date: 12/06/2019

Medical Identifiers

Medical identifiers for Mary Sue Wester such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538706726	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083X0100X	Preventive Medicine - Occupational Medicine	17655 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mary Sue Wester is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mary Sue Wester, MD 6101 Virginia Ave. N, New Hope, MN 55428 Ph: () -	Mary Sue Wester, MD 6101 Virginia Ave. N, New Hope, MN 55428 Ph: (763) 537-6307

News Archive

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.

Double-disease burden in India

It has been known that countries with rapidly developing economies may experience a double-disease burden that results from undernutrition and overnutrition.

House votes to delay health law's mandates

Despite White House veto threats, House lawmakers on Wednesday OK'd two separate bills amending portions of the Affordable Care Act, the latest GOP moves to try to scuttle the health law. A measure putting off the employer mandate was approved 264-161 while a bill delaying the individual mandate passed 251-174.

Okayama University researchers identify link between plant complex type N-glycans and hay fever

Okayama University researchers identify plants expressing substantial amounts of a nitrogen-linked polysaccharide – plant complex type N-glycans – which is linked to allergic responses in mammals, and may provide useful study models for understanding hay fever.

Mary Sue Wester, MD - Preventive Medicine in New Hope, MN